If a study comes up negative for your favorite drug, just don’t publish it! 68 percent of all drug studies are swept under the carpet to keep those pesky side effects from being reported. Only 32 percent of studies come up positive, and a lot of those studies are “shortened” to limit the long-term findings. Studies cut short were found to overestimate the study drug’s effectiveness and miss dangerous side effects and complications by an average of 30 percent. This would explain the amazing 85 percent drug study success rate in the hands of Big Pharma according to the Annals of Internal Medicine.
In some cases, shortened studies don’t just make a drug look more effective than it ever could be, but they also turn dangerous and ineffective meds into miracle drugs, according to a study in JAMA. Studies are often cut short when researchers get “overwhelmingly convincing evidence” of a drug’s effectiveness. If you want to make money with your drug, find an early spike in the data and run with it before the data dives. Get in, get the result you want, get out fast, and make lots of money.